Filana Therapeutics, Inc. (FLNA)
0.7968
-0.02
(-2.32%)
USD |
NASDAQ |
Oct 08, 12:50
Filana Therapeutics EPS Diluted (Quarterly) : -0.1781 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.1781 |
| March 31, 2026 | -0.2139 |
| December 31, 2025 | -0.2596 |
| September 30, 2025 | -0.2237 |
| June 30, 2025 | -0.9155 |
| March 31, 2025 | -0.4849 |
| December 31, 2024 | -0.5738 |
| September 30, 2024 | -0.5824 |
| June 30, 2024 | 0.1332 |
| March 31, 2024 | -0.4251 |
| December 31, 2023 | -0.4958 |
| September 30, 2023 | -0.6107 |
| June 30, 2023 | -0.6311 |
| March 31, 2023 | -0.5815 |
| December 31, 2022 | -0.4693 |
| September 30, 2022 | -0.5058 |
| June 30, 2022 | -0.483 |
| March 31, 2022 | -0.4386 |
| December 31, 2021 | -0.3546 |
| September 30, 2021 | -0.2393 |
| June 30, 2021 | -0.1283 |
| March 31, 2021 | -0.0935 |
| December 31, 2020 | -0.0868 |
| September 30, 2020 | -0.0573 |
| June 30, 2020 | -0.0458 |
| Date | Value |
|---|---|
| March 31, 2020 | -0.047 |
| December 31, 2019 | -0.0835 |
| September 30, 2019 | -0.0406 |
| June 30, 2019 | -0.0617 |
| March 31, 2019 | -0.0792 |
| December 31, 2018 | -0.0394 |
| September 30, 2018 | -0.11 |
| June 30, 2018 | -0.36 |
| March 31, 2018 | -0.33 |
| December 31, 2017 | -0.37 |
| September 30, 2017 | -0.40 |
| June 30, 2017 | -0.64 |
| March 31, 2017 | -0.42 |
| December 31, 2016 | -0.42 |
| September 30, 2016 | -0.56 |
| June 30, 2016 | -0.49 |
| March 31, 2016 | -0.91 |
| December 31, 2015 | -0.70 |
| September 30, 2015 | -0.56 |
| June 30, 2015 | -0.49 |
| March 31, 2015 | -0.42 |
| December 31, 2014 | -0.35 |
| September 30, 2014 | -0.56 |
| June 30, 2014 | -0.49 |
| March 31, 2014 | -0.56 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| CorMedix, Inc. | 0.281 |
| Eloxx Pharmaceuticals, Inc. | -0.6631 |
| BioStem Technologies, Inc. | -0.5178 |
| Wave Life Sciences, Inc. | -0.34 |
| Axsome Therapeutics, Inc. | -0.9906 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -8.603M |
| Total Expenses (Quarterly) | 8.603M |
| Enterprise Value | -43.28M |
| Earnings Yield | -109.9% |
| Normalized Earnings Yield | -109.84 |